Physician Assistant, Surgical · Yuba City, CA
NPI
1124074877
Since 2006
Specialty
Physician Assistant, Surgical
Code 363AS0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
350 del Norte Avenue
Yuba City, CA, 95991
Phone (530) 671-4182
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
4,013 services
Medicare patients, 2024
652
Average age 75
Drug cost, 2024
$292K
769 prescriptions
Company payments, 2025
$5,312
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Greg S Chance was code 17003 (destruction skin lesion), 1,298 times for 176 patients. In total Greg S Chance billed 4,013 services in 61 codes, and Medicare paid $191K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,298 | 176 | $3.92 | $5,086 |
| 99213 Office E&M - Established | Office | 793 | 452 | $51.36 | $41K |
| 17110 Destruction Skin Lesion | Office | 337 | 259 | $67.98 | $23K |
| 11102 Skin Biopsy | Office | 307 | 258 | $44.29 | $14K |
| 17000 Destruction Skin Lesion | Office | 264 | 198 | $24.81 | $6,550 |
| 99203 Office E&M - New | Office | 223 | 223 | $56.90 | $13K |
| 17004 Destruction Skin Lesion | Office | 183 | 137 | $96.69 | $18K |
| 11103 Skin Biopsy | Office | 138 | 99 | $29.49 | $4,070 |
| 17111 Destruction Skin Lesion | Office | 109 | 95 | $81.84 | $8,920 |
| 13132 Wound Repair - All Levels | Office | 39 | 35 | $300.69 | $12K |
| 11602 Skin Lesion Excision | Office | 32 | 30 | $71.86 | $2,300 |
| 13101 Wound Repair - All Levels | Office | 32 | 29 | $244.65 | $7,829 |
| 11642 Skin Lesion Excision | Office | 31 | 26 | $88.53 | $2,744 |
| 13121 Wound Repair - All Levels | Office | 25 | 24 | $280.05 | $7,001 |
| 11622 Skin Lesion Excision | Office | 15 | 15 | $78.20 | $1,173 |
By year: 2022 $109K for 2,105 services; 2023 $181K for 3,743 services; 2024 $191K for 4,013 services.
Medicare prescription drug claims, 2024
In 2024, the drug Greg S Chance prescribed most often to Medicare patients was Ketoconazole, with 187 prescriptions and refills. In total Greg S Chance wrote 769 Medicare prescriptions that cost $292K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 187 | 192 | 102 | $2,889 |
| Triamcinolone Acetonide Generic | 141 | 146 | 92 | $1,347 |
| Cephalexin Generic | 102 | 102 | 91 | $725 |
| Fluocinonide Generic | 53 | 57 | 37 | $2,025 |
| Zoryve Roflumilast | 49 | 61 | 25 | $40K |
| Erythromycin Erythromycin Base In Ethanol | 42 | 44 | 26 | $1,168 |
| Hydroxyzine Hcl Generic | 38 | 51 | 19 | $351 |
| Clobetasol Propionate Generic | 29 | 29 | 16 | $727 |
| Fluorouracil Generic | 17 | 19 | 16 | $1,321 |
| Minocycline Hcl Generic | 14 | 14 | Under 11 | $365 |
| Tretinoin Generic | 11 | 12 | Under 11 | $914 |
| Doxycycline Hyclate Generic | 11 | 11 | Under 11 | $223 |
Brand drugs: 79 claims; generic drugs: 690 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Greg S Chance $5,312 ($5,312 in general payments such as food, travel and fees) from 14 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $4,328.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 27 | $4,328 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $198 |
| UCB, Inc. UCB.BR | 13 | $174 |
| Abbvie Inc. ABBV | 12 | $154 |
| Pfizer Inc. PFE | 1 | $95.35 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $78.31 |
| Organon LLC OGN | 4 | $66.42 |
| Amgen Inc. AMGN | 2 | $47.38 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $47.14 |
| Verrica Pharmaceuticals Inc. VRCA | 2 | $43.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.